Third View Private Wealth
NVO icon

Third View Private Wealth’s Novo Nordisk NVO Stock Holding History

Third View Private Wealth’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.21M Buy
84,641
+10,431
+14% +$481K 0.38% 68
2026
Q2 		$3.56M Sell
74,210
-6,228
-8% -$268K 0.44% 53
2026
Q1 		$2.96M Buy
80,438
+10,363
+15% +$491K 0.4% 62
2025
Q4 		$3.57M Buy
+70,075
New +$3.58M 0.48% 43

Other funds holding NVO

Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Everett Harris & Co
Everett Harris & Co Los Angeles, California $8.46B AUM 13.48% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Saratoga Research & Investment Management
Saratoga Research & Investment Management Saratoga, California $1.82B AUM 11.8% 1-Year Est. Return
Markel Group
Markel Group Glen Allen, Virginia $12.8B AUM 8.77% 1-Year Est. Return
Natixis
Natixis Paris, France $28B AUM 27.03% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Oppenheimer Asset Management
Oppenheimer Asset Management New York $9.5B AUM 23.46% 1-Year Est. Return

Third View Private Wealth's NVO Position: Q3 2026 in Review

Third View Private Wealth increased its Novo Nordisk (NVO) stake by 14% in Q3 2026, buying an estimated $481K and bringing the position to 84,641 shares worth $3.21M. The position accounts for 0.38% of the portfolio, ranked #68.

Third View Private Wealth first reported a position in NVO in Q4 2025 and has held it in 4 quarters since. The position peaked at $3.57M in Q4 2025. 696 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • Third View Private Wealth held 84,641 shares of Novo Nordisk worth $3.21M as of Q3 2026.
  • Third View Private Wealth bought 10,431 Novo Nordisk shares in Q3 2026, an estimated $481K.
  • Novo Nordisk made up 0.38% of Third View Private Wealth's portfolio in Q3 2026, its #68 holding.
  • Third View Private Wealth first reported a position in Novo Nordisk in Q4 2025 and has held it in 4 quarters since.
  • Third View Private Wealth's Novo Nordisk position peaked at $3.57M in Q4 2025.
  • 696 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Third View Private Wealth's 13F filing for Q3 2026, filed 30 Oct 2026.